Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Meta-analysis reveals key risk factors for liver toxicity in cancer patients receiving immunotherapy
Meta-analysis reveals DPYD gene variants significantly increase death risk in fluoropyrimidine chemotherapy.
New trial compares short-course radiotherapy plus chemotherapy to standard chemoradiotherapy for rectal cancer
New drug combination significantly improves outcomes for patients with advanced colorectal cancer
Study finds fucoidan supplement improves physical well-being in rectal cancer patients receiving chemoradiation
Study explores effects of curcumin and anthocyanins on biomarkers in patients with colorectal adenomas
Study finds cetuximab maintenance may benefit some colorectal cancer patients after initial treatment
Study shows zinc supplements decrease severe hand-foot skin reactions from regorafenib cancer drug